LAMB1 and metastatic prostate carcinoma: (2024) identified LAMB1 as a small EV (sEV) protein significantly enriched in the plasma of patients with metastatic prostate cancer, highlighting its potential as a biomarker for diagnosis and risk stratification (Pang et al.